Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma
This cohort study of LRT-IO with long-term follow-up data found a durable response in patients with locally advanced unresectable HCC. Long-term survival was attainable in patients with radiologic CR. Further randomized clinical trials are warranted.
Authors
- Albert Chan (ORCID: https://orcid.org/0000-0002-1383-2952)
- Kwan Man (ORCID: https://orcid.org/0000-0001-5663-6866)
- Venus Wan Yan Lee
- K.W. Chiu (ORCID: https://orcid.org/0000-0002-7930-1193)
- Kenneth Sik Kwan Chan
- Chi‐Leung Chiang (ORCID: https://orcid.org/0000-0002-9836-6478)
- Natalie Wong (ORCID: https://orcid.org/0000-0001-9419-8908)
- Francis Ann Shing Lee
- Feng‐Ming Kong (ORCID: https://orcid.org/0000-0003-2652-098X)
- Wenqi Chen (ORCID: https://orcid.org/0000-0002-5348-2977)
- Ryan Lok Man Ho
Institutions
- Chinese University of Hong Kong (HK)
- Kwong Wah Hospital (CN)
- Tuen Mun Hospital (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1001/jamaoncol.2024.4085
- Citations
- 24
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 8.87